What Happened?
New York, NY-based Click Therapeutics Inc. Appointed David Klein as Chief Executive Officer, Co-Founder, Executive Chairman
About the Company
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click is also progressing a broad pipeline of prescription Digital Therapeutics across a variety of high-burden therapeutic areas, including Major Depressive Disorder, Schizophrenia, Acute Coronary Syndrome, Migraine, Chronic Pain, Insomnia, COPD, Obesity, and more.
About the Person
David Klein is Chief Executive Officer, Co-Founder, Executive Chairman at Click Therapeutics, Inc.. Previously, David held various senior HR leadership roles in the industry.
Info Source
News
Short Profile